Fei Yang Cao

Fei Yang Cao is the dried whole herb of Euphorbia hirta L., an annual or sometimes perennial herbaceous plant in the family Euphorbiaceae (spurge family). In the traditional TCM classification system, Fei Yang Cao is considered slightly bitter and slightly astringent in flavor with a cool nature. It enters the Lung, Large Intestine, and Liver meridians, giving it a role in formulas that address damp-heat, heat-toxin, itching, and insufficient lactation.

Botanical description: Euphorbia hirta is a small, erect or prostrate annual herb growing 20–50 cm tall, though prostrate forms can spread much wider. The stems are slender, often reddish, and covered with fine, soft hairs (hence the species epithet "hirta," meaning hairy). The leaves are opposite, simple, elliptic to oblong, 1–4 cm long and 0.5–2 cm wide, with finely serrated margins, a slightly hairy surface, and short petioles. The inflorescences are characteristic cyathia — the specialized floral structure unique to the Euphorbia genus — arranged in dense axillary clusters. Each cyathium is cup-shaped with a single female flower surrounded by several male flowers, subtended by conspicuous white or pale green petal-like appendages (involucral glands). The fruit is a small, three-lobed capsule. The entire plant exudes a white, milky latex when broken or cut, which is characteristic of the Euphorbiaceae family.

Habitat and distribution: E. hirta is a pantropical weed with an extremely wide distribution across tropical and subtropical regions of the world. In China, it is found in the southern provinces of Guangdong, Guangxi, Fujian, Yunnan, Guizhou, Hainan, and Taiwan, as well as in parts of Sichuan and Hunan. Globally, it is distributed throughout Southeast Asia, India, Africa, Central and South America, and the Caribbean. The plant is a common weed in cultivated fields, waste areas, roadsides, lawns, and disturbed sites. It thrives in warm, humid environments with well-drained soils and is highly adaptable, often colonizing disturbed ground rapidly. The herb is harvested during the flowering period (typically summer to early autumn) and dried in the sun or shade for medicinal use.

Quality markers: High-quality Fei Yang Cao should consist of whole or nearly whole plants with green to reddish-green stems, green leaves with intact margins, and visible flower clusters. The herb should have a slight, characteristic odor and a slightly bitter, astringent taste. Premium-grade material is characterized by its fresh green color, minimal yellowing or browning, absence of mold or excessive soil contamination, and the presence of both leaves and flowering tops. The latex content should be evident when fresh material is handled. The herb should be free of other weed species and extraneous plant material.

In the traditional Chinese medicine theoretical framework, Fei Yang Cao is understood in terms of its effects on specific patterns of disharmony (zheng). Because it enters the Lung, Large Intestine, and Liver meridians and has a slightly bitter, slightly astringent, and cool quality, it is traditionally indicated for patterns involving damp-heat, heat-toxin, itching, and insufficient lactation.

Clearing heat and resolving toxicity: Fei Yang Cao is traditionally used to clear heat and resolve toxicity in conditions involving damp-heat accumulation. In TCM theory, damp-heat in the Large Intestine may present as diarrhea, dysentery with mucus and blood, and tenesmus. Fei Yang Cao addresses these patterns through its combined heat-clearing and astringent properties, helping to both eliminate the pathogenic factors and arrest the fluid loss. It may be combined with Huang Lian and Huang Qin for damp-heat in the Large Intestine. This traditional use is based on TCM pattern differentiation and should not be equated to specific antimicrobial or antidiarrheal diagnoses.

Stopping itching and treating skin conditions: Fei Yang Cao is one of the herbs traditionally used for pruritus (itching) and various skin conditions associated with damp-heat or wind-heat. In TCM theory, itching of the skin may be caused by wind-heat, damp-heat, or blood deficiency generating wind. Fei Yang Cao is particularly suitable for itching associated with damp-heat, presenting as eczema, dermatitis, urticaria, and pruritic skin eruptions. It can be used both internally as a decoction and externally as a wash or poultice. For external application, the fresh plant or a concentrated decoction is applied directly to affected skin areas. The cool and astringent properties are believed to relieve inflammation, reduce exudation, and stop itching.

Promoting lactation: A distinctive traditional use of Fei Yang Cao is its ability to promote lactation in postpartum women. In TCM theory, insufficient lactation may result from Liver Qi stagnation obstructing the milk ducts or from deficiency of Qi and Blood failing to nourish the breast. Fei Yang Cao enters the Liver meridian and is believed to help smooth the flow of Liver Qi and promote milk production. This traditional use is relatively unique among herbs in the heat-clearing category. It is typically prepared as a decoction or the fresh herb is juiced for consumption. The mechanism of this lactogenic effect is not well understood from a modern pharmacological perspective.

Respiratory conditions: Fei Yang Cao enters the Lung meridian and has been traditionally used for respiratory conditions involving heat and phlegm. In TCM practice, it may be used for cough with phlegm, wheezing, and bronchitis patterns associated with Lung heat. Some traditional texts describe its use for asthma-like breathing difficulties. This traditional application has parallels in Ayurvedic medicine, where Euphorbia hirta is used as a remedy for respiratory conditions. These uses reflect traditional theoretical frameworks and are not equivalent to modern respiratory medicine diagnoses.

Classical literature references: Fei Yang Cao is documented in several traditional Chinese medicine texts and regional herbals. The Ben Cao Shi Yi (Supplement to the Materia Medica) and various southern Chinese provincial herbals recorded its use for clearing heat, stopping diarrhea, and treating skin conditions. The Guangxi Zhong Cao Yao Zhi(Guangxi Chinese Materia Medica Record) documented its use for damp-heat diarrhea, eczema, and insufficient lactation. The herb has also been recorded in the Zhong Hua Ben Cao (Chinese Materia Medica) with comprehensive monographic information summarizing its traditional uses and pharmacological research.

Fei Yang Cao contains a diverse array of bioactive compounds that have been the subject of phytochemical and pharmacological investigation. The following overview summarizes the major chemical constituents identified in the whole herb of Euphorbia hirta and what is currently known about them from published research.

Quercetin: Quercetin is a flavonol and one of the most abundant and well-studied flavonoids in Fei Yang Cao. It has been extensively investigated for its antioxidant, anti-inflammatory, antiallergic, and anticancer properties in pre-clinical research. Quercetin's antioxidant activity is mediated through free radical scavenging and modulation of oxidative stress pathways. Its anti-inflammatory effects involve inhibition of pro-inflammatory mediators (TNF-alpha, IL-6, COX-2, and NF-kappaB signaling). The antiallergic properties are attributed to mast cell stabilization and inhibition of histamine release. While quercetin is a promising compound in pre-clinical research, its bioavailability is relatively low when taken orally, and clinical evidence from well-designed trials in humans remains limited.

Kaempferol: Kaempferol is a flavonol closely related to quercetin and another significant constituent of Fei Yang Cao. It has been studied for its anti-inflammatory, antioxidant, cardioprotective, and potential anticancer activities in pre-clinical models. Kaempferol inhibits several signaling pathways involved in inflammation and cell proliferation, including PI3K/Akt and MAPK pathways. Epidemiological studies have suggested an association between dietary kaempferol intake and reduced risk of certain chronic diseases, though causal relationships have not been established. As with quercetin, the bioavailability of kaempferol is a significant limitation for its therapeutic potential.

Gallic acid: Gallic acid is a phenolic acid widely distributed in plants and present in Fei Yang Cao. It is a well-characterized antioxidant and antimicrobial compound. Gallic acid has been studied for its ability to scavenge reactive oxygen species, inhibit lipid peroxidation, and protect cellular components from oxidative damage. Its antimicrobial activity has been demonstrated against a range of bacterial and fungal pathogens in in-vitro studies. Gallic acid also exhibits anti-inflammatory properties through modulation of inflammatory signaling cascades. The gallic acid content contributes to the overall antioxidant and toxicity-resolving properties traditionally attributed to Fei Yang Cao.

Euphorbin and diterpenoids: Euphorbin (also known as euphorbin A or related diterpene lactones) is a characteristic compound of the Euphorbia genus. These diterpenoid compounds are found in the milky latex of the plant and are responsible for the irritant properties of Euphorbia species. Diterpenoids from Euphorbia have been studied for their anti-inflammatory, antitumor, and immunomodulatory activities in pre-clinical models. However, they can also cause skin and mucous membrane irritation and may have toxic effects at higher doses. The euphorbin content of E. hirta is generally lower than in some other Euphorbia species, but it still warrants caution in internal use.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

Fei Yang Cao is used in several formula contexts in the TCM tradition, particularly those addressing damp-heat conditions, skin disorders, and insufficient lactation. Below are three representative formula contexts that feature this herb, along with their traditional indications and the role it plays in each composition.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Antimicrobial and antifungal activity: Extracts of Euphorbia hirta have been studied for their antimicrobial properties against a range of bacterial and fungal pathogens. Pre-clinical studies have demonstrated inhibitory activity against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis, and various Candidaspecies in vitro. The antimicrobial activity is attributed to the combined effects of flavonoids (quercetin, kaempferol), phenolic acids (gallic acid), and diterpenoid compounds. Mechanisms of action include disruption of microbial cell membrane integrity, inhibition of efflux pumps, and interference with microbial enzyme systems. While these findings are mechanistically interesting, the clinical relevance of these antimicrobial effects for treating human infections has not been established through clinical trials.

Anti-inflammatory and antioxidant effects: The flavonoid-rich extracts of E. hirta have demonstrated significant anti-inflammatory and antioxidant activities in pre-clinical models. In animal studies, E. hirta extracts reduced carrageenan-induced paw edema and decreased the production of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) in inflamed tissues. The antioxidant activity has been demonstrated through scavenging of DPPH and ABTS radicals, reduction of lipid peroxidation, and enhancement of endogenous antioxidant enzyme activities (superoxide dismutase, catalase, glutathione peroxidase). The anti-inflammatory effects are associated with modulation of NF-kappaB and MAPK signaling pathways. These pre-clinical findings suggest potential mechanisms consistent with the herb's traditional use in clearing heat and resolving toxicity, but they do not constitute evidence for clinical efficacy in human inflammatory conditions.

Anti-diarrheal and gastrointestinal effects: Pre-clinical studies have investigated the anti-diarrheal properties of E. hirtain animal models. Research has shown that E. hirta extracts reduced the frequency and severity of castor oil-induced diarrhea in mice and decreased intestinal fluid accumulation. The anti-diarrheal effect may be attributed to the astringent tannin content, which reduces intestinal secretion and promotes water reabsorption, combined with the antimicrobial activity against enteropathogenic bacteria. Additionally, some studies have reported spasmolytic effects on isolated intestinal smooth muscle. These findings are consistent with the traditional use of Fei Yang Cao for damp-heat diarrhea and dysentery, but clinical trials in humans are lacking.

Anti-asthmatic and bronchodilatory effects: Some pre-clinical studies have investigated the potential anti-asthmatic properties of E. hirta. Research has demonstrated that E. hirta extracts can relax pre-contracted tracheal smooth muscle in animal models, suggesting bronchodilatory activity. The mechanism may involve inhibition of calcium influx into smooth muscle cells and modulation of adrenergic receptors. Quercetin, a major constituent, is known to inhibit mast cell degranulation and histamine release, which may contribute to antiallergic and anti-asthmatic effects. These findings are mechanistically interesting but should not be extrapolated to clinical applications in human respiratory diseases.

What the research does NOT show: Despite promising pre-clinical signals, the research on Fei Yang Cao does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. There are no large-scale, randomized, placebo-controlled clinical trials that establish Fei Yang Cao as an effective treatment for diarrhea, skin conditions, respiratory diseases, insufficient lactation, or any other medical condition. The popular use in some folk medicine traditions (such as for dengue fever in the Philippines) is not supported by robust clinical evidence. The translation from animal models and in-vitro experiments to human clinical relevance is uncertain. This page does not endorse Fei Yang Cao as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: Fei Yang Cao is widely used in folk medicine and TCM practice, but its safety profile requires careful consideration due to the presence of irritant latex compounds (diterpenes) characteristic of the Euphorbia genus. While E. hirta is generally considered less toxic than some other Euphorbia species (such as E. pekinensis or E. kansui), it is not free of risk. The information below reflects what is currently known from published literature and traditional clinical experience.

Latex irritant effects: Like all Euphorbia species, E. hirta produces a white, milky latex containing diterpenoid compounds (euphorbin and related substances) that are skin and mucous membrane irritants. Direct contact with the latex can cause contact dermatitis, redness, itching, and in some cases, blistering. Eye contact with the latex is particularly dangerous and may cause conjunctivitis or corneal damage. Individuals handling the fresh plant should avoid touching their eyes and should wash their hands thoroughly after contact. Sensitive individuals or those with a history of contact dermatitis to Euphorbiaceae plants should use particular caution.

Pregnancy and lactation: Fei Yang Cao should be used with caution during pregnancy. The diterpenoid compounds in the latex may have stimulant effects on smooth muscle, including uterine muscle, which could theoretically increase the risk of premature contractions. While the herb has been traditionally used to promote lactation in postpartum women, its safety during pregnancy has not been adequately studied. Self-administration during pregnancy is not recommended. During lactation, its use should be guided by a qualified healthcare professional.

Spleen-Stomach deficiency-cold: In traditional TCM theory, the cool and astringent nature of Fei Yang Cao may worsen digestive weakness in individuals with Spleen-Stomach deficiency-cold patterns. Symptoms such as poor appetite, loose stools (not due to damp-heat), abdominal coldness, and a pale tongue with white coating may be worsened by the cool and astringent properties of this herb. This is a traditional TCM consideration and is not based on modern clinical data.

Constipation: Due to its astringent properties, Fei Yang Cao may worsen constipation. Individuals with a tendency toward constipation or with dry intestine patterns should use this herb with caution. This astringent effect is a direct pharmacological property of the tannin and flavonoid constituents.

Drug interactions: Pre-clinical data suggest that quercetin in Fei Yang Cao may inhibit cytochrome P450 enzymes (CYP3A4, CYP2C9, CYP2D6) and P-glycoprotein efflux transporters, potentially affecting the metabolism and absorption of concomitant medications. The tannin content may reduce the absorption of iron supplements and some antibiotics. Clinical interaction data for whole-herb Fei Yang Cao in humans are very limited. Consult a qualified healthcare professional before combining this herb with any prescription medications.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Fei Yang Cao or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.